Advisor Group Holdings, Inc. Acurx Pharmaceuticals, Inc. Transaction History
Advisor Group Holdings, Inc.
- $43.4 Billion
- Q1 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 57,250 shares of ACXP stock, worth $128,812. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,250
Previous 57,250
-0.0%
Holding current value
$128,812
Previous $219,000
36.07%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ACXP
# of Institutions
30Shares Held
1.25MCall Options Held
16.1KPut Options Held
33.8K-
Vanguard Group Inc Valley Forge, PA492KShares$1.11 Million0.0% of portfolio
-
Prospect Financial Services LLC Melville, NY273KShares$613,9120.55% of portfolio
-
Geode Capital Management, LLC Boston, MA116KShares$261,7920.0% of portfolio
-
State Street Corp Boston, MA43.5KShares$97,7980.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC40.2KShares$90,5280.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $26M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...